Two Sigma Securities »

Design Therapeutics shares owned by Two Sigma Securities

Quarter-by-quarter ownership of Design Therapeutics (DSGN) shares owned by Two Sigma Securities from 13F filings

Historical chart of Two Sigma Securities investment in Design Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Design Therapeutics held by Two Sigma Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Design Therapeutics by Two Sigma Securities

Quarter filed Position value Share count Share price at filing
2025-12-31 $107k 11k 9.38

More positions owned by Two Sigma Securities

Ishares Tr Iboxx Hi Yd Etf (HYG)
Microsoft Corporation (MSFT)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Spdr Series Trust State Street Spd (BIL)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Tesla Motors (TSLA)
NVIDIA Corporation (NVDA)
Vanguard Scottsdale Fds Shrt Trm Corp Bd (VCSH)
Ishares Tr Core Msci Total (IXUS)
Oracle Corporation (ORCL)
Ishares Tr Core Univrsl Usd (IUSB)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Alphabet Cap Stk Cl C (GOOG)
Ishares Tr Broad Usd High (USHY)
Invesco Exch Traded Fd Tr Ii Sr Ln Etf (BKLN)

View all positions for Two Sigma Securities

Top funds holding Design Therapeutics

Sr One Capital Management
Point72 Asset Management
Logos Global Management
BlackRock
Baker Bros. Advisors
Vanguard Group
Vivo Capital
Almitas Capital
Driehaus Capital Management
Woodline Partners
Kynam Capital Management
FMR
Geode Capital Management
State Street Corporation
Acadian Asset Management

View all funds holding Design Therapeutics